ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 693

Acute Myocarditis in Patients with Systemic Lupus Erythematosus: Experience from Affiliated Hospitals of Catholic University of Korea

In-Woon Baek1, Ki-Jo Kim2, Yune-Jung Park3, Chong-Hyeun Yoon4, Wan-Uk Kim5 and Chul-Soo Cho1, 1Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea, 2Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, South Korea, 3Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, South Korea, 4Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Uijeongbu, South Korea, 5Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Myocardial involvement, risk assessment and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Treatment and Management Studies

Session Type: Abstract Submissions (ACR)

Background/Purpose: To determine the factors associated with occurrence of acute myocarditis (AMC) and its outcomes in patients with systemic lupus erythematosus (SLE). 

Methods: This was a retrospective study of hospitalized SLE patients with AMC from 2002 to 2014 at Catholic University affiliated hospitals. A diagnosis of AMC was made on the basis of clinical findings, electrocardiographic changes, elevated cardiac enzymes levels and echocardiographic abnormalities. Eighty-six SLE patients who showed no echocardiographic evidence of myocarditis were enrolled as a control group. The clinical and laboratory data from each patient were collected from the charts and compared between 2 groups. 

Results: During these periods, 22 SLE patients were identified to have AMC (male 3, female 19). Patients with AMC, as compared with those without, were found to be associated with shorter disease duration and higher frequency of smoking (P<0.005, P<0.05, respectively). Moreover, they showed significantly higher SLE disease activity index score (P<0.001) and C-reactive protein levels (P<0.001), but lower complement levels (C3, C4 and CH50, all P<0.005). Interestingly, antiphospholipid syndrome (APS) was more prevalent in patients with AMC compared with those without (P<0.01). In multivariate analysis, shorter disease duration, smoking and presence of APS were independent factors associated with AMC in SLE patients. All patients with AMC received high-dose corticosteroid and 2 of them received intravenous cyclophosphamide; 17 patients completely recovered, but 5 died. 

Conclusion: AMC patients are more likely to have high disease activity and its occurrence is associated with shorter disease duration, smoking, and presence of APS.


Disclosure:

I. W. Baek,
None;

K. J. Kim,
None;

Y. J. Park,
None;

C. H. Yoon,
None;

W. U. Kim,
None;

C. S. Cho,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/acute-myocarditis-in-patients-with-systemic-lupus-erythematosus-experience-from-affiliated-hospitals-of-catholic-university-of-korea/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology